Physician profile
William A Hunt
NPI 1396744041
$500.91
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $79.07 · 2021: $71.21 · 2022: $37.24 · 2023: $47.82 · 2024: $58.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105 · Education: $1.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.84 |
| Education | $1.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $148.71 | 2019-2024 | Farxiga |
| Amgen INC. | $80.89 | 2019-2020 | |
| Vifor Pharma, INC. | $61.21 | 2019 | |
| Alexion Pharmaceuticals, INC. | $34.81 | 2019 | |
| Ardelyx, INC. | $34.10 | 2024 | Ibsrela |
| Akebia Therapeutics INC | $32.12 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.39 | 2023 | |
| Aurinia Pharma U.S., INC. | $23.19 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.94 | 2019 | |
| Fresenius USA Marketing, INC. | $18.95 | 2020 | |
| Baxter Healthcare | $14.29 | 2020 | |
| Travere Therapeutics, INC. | $1.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.